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ABSTRACT 
This study was contrived for evaluating the in vitro and in vivo anti-inflammatory effects of 
an aqueous ethanolic leaf extract of the Vietnamese Artocarpustonkinensis A. Chev. exGagnep. 
usinglipopolysaccharide-stimulated RAW 264.7 macrophages and a collagen antibody-induced 
arthritic mouse model as well. The obtained results here demonstrate that the 70 % ethanolic leaf 
extract of A. tonkinensis(AT2), traditionally used in Vietnamese folk medicine for treating 
arthritic symptoms, has beneficial effects on pro-inflammatory cytokine inhibition and in an 
experimental arthritic mouse model.LPS-stimulated RAW 264.7 macrophages treated with AT2 
showed a significant decrease in the production of IL-6 and TNF  at concentrations of 12.5, 25 
and 50 µg/mL (P < 0.05), indicating its potential anti-inflammatory properties. The treatment of 
CAIA mice with AT2 also led to diminish the incidence of arthritis at doses of 200 and 300 
mg/kg body weight. 
Keywords: Artocarpustonkinensis, autoimmune, interleukin 6, inflammation, rheumatoid 
arthritis. 
Classification numbers:  1.1.1; 1.2.1 
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1. INTRODUCTION 
Inflammation is involved in the development of conditions such as autoimmune disease [1, 
2]and rheumatoid arthritis [3, 4]. The major classes of drugs used to suppress inflammation are 
nonsteroidal anti-inflammatory agents and corticosteroids, but their toxic adverse effects such as 
epigastric distress, peptic ulceration and osteoporosis have limited their use [5]. Considering that 
different medicinal compounds, derived from plant sources, such as flavonoids, flavonoid 
glycosides, stilbenoidsand saponins, may represent new anti-inflammatory agents more 
efficacious, safer, affordable, and accessible for patients, this path of searching for new drugs 
should be taken in serious consideration. 
ArtocarpustonkinensisA.Chev. exGagnep. is a tree currently found in North Vietnam. The 
decoction of its leaves and roots is used in traditional knowledgeto treat backache, arthritis and 
joint disorders. Our previous phytochemical analysis of the A. tonkinensisleaves revealed the 
presence of flavonoid compounds such as auronol, kaempferol, quercetin and their glycosides 
[6-8].Of them, two auronolglucosides (1 and 2) were found to have potent immunomodulatory, 
anti-proliferative and anti-inflammatory activities[9-11].For a possible use of 70% ethanolic 
extract of A. tonkinensisleaves as alternative herb medicines to treat human disease, this study 
wasundertaken to evaluate its possible anti-inflammatory activities in vitro using LPS-stimulated 
RAW 264.7 macrophages and in vivo using a collagen antibody-induced arthritic BALB/c 
mouse model. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Dulbecco’s Modified Eagle’s Medium (DMEM) and antibiotic - antimycotic were 
purchased from Invitrogen(Carlsbad, CA, USA). Fetal bovine serum (FBS), lipopolysaccharides 
(LPS) and3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltertazolium bromide (MTT) were obtained 
from Sigma Chemical Co. (St. Louis, MO., USA). TNF-alpha and IL-6 ELISA kits were 
purchased from Biovision (Chester Springs, PA, USA). The collagen antibody cocktail was 
purchased from Modi Quest Research (Nijmegen, The Netherlands). 
2.2. Preparation of ethanolic extract of A. tonkinensis leaves (AT2)  
Leaves of A. tonkinensis were collected in Hanoi, Vietnam (October 2016) and identified 
by the taxonomist – Ngo Van Trai (National Institute of Medicinal Materials, Hanoi, Vietnam). 
The voucher specimen (Nr. 1482-AT-2016) was deposited in the Institute of Chemistry, 
Vietnam Academy of Science and Technology (ICH, VAST) for further reference.  
In a pre-experiment, it was found that application of 70 % ethanol to extract the dried 
leaves of A. tonkinensis possessed high total phenolic content. Thus, 70 % ethanol was used for 
this extraction. Dried ground of A. tonkinensis leaves (600g) were extracted with 70 % EtOH, 
each 3 litres, overnight, x3 times) at RT. The extract was filtered and concentrated under 
reduced pressure in a rotary evaporator at 50-60 
o
C until the aqueous volume reduced to one 
third of its original volume and then freeze-dried. The crude ethanolic extract (110 g) was a 
brown powder, of which the obtained yield was 18.3 % (w/w). 
2.3. Phytochemical analysis of AT2 
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To obtain the purified flavonoids for the chemical structural analysis, a large-scale isolation 
was carried out as previously described and their structures were confirmed by comparing their 
ESI-MS,
 1
H and 
13
C NMR data with reported data[6, 8].AT2 was fractionated by a classical 
chromatography methodology. Columns packed with DIAION HP-20 and Sephadex LH-20 
adsorbents were efficient for the isolation of nine compounds. Two auronolglucosidemaesopsin 
4-O- -glucopyranoside (hovetrichoside C, 1), alphitonin-O- -glucopyranoside (2), as well as 
kaempferol(3),astragalin (4), kaempferol 3-O- -rutinoside (5), kaempferol 3-O- -
neohesperidoside(6), quercetin, quercetin 3-O- -glucopyranoside (7),afzelechin-(4 8″)-
catechin-3-O- -glucopyranoside(8) and catechin(9) were identified [6, 8]. The AT2 extract was 
analyzed for the presence of various phytochemical constituents employing screening TLC. The 
detailed qualitative analyses of AT2 extract was performed with HPLC method. The presence of 
flavonoids 1-9 (Figure 1) in AT2 was examined by high-performance liquid chromatography 
coupled with mass spectrum (HPLC-MS), with UV detection. 
Table 1. The MS data of isolated compounds from ethanolic extract of A. tonkinensis leaves (AT2)
a
 
Comp. Name of compounds
 b
 Molecular 
formula 
Molecular 
ion (m/z) 
Rt
c
(min
.) 
1 hovetrichoside C C21H22O11 473[M+Na]
+
 10.89 
2 alphitonin-O- -D-glucopyranoside C21H22O12 489[M+Na]
+
 9.41 
3 kaempferol C15H10O6 287 [M+H]
+
 16.29 
4 astragalin C21H20O11 449 [M+H]
+
 14.70 
5 kaempferol 3-O- -rutinoside C27H30O15 617 [M+Na]
+
 
593 [M-H]
-
 
c 
6 kaempferol 3-O- -neohesperidoside C27H30O15 
c 
7 quercetin 3-O- -D-glucopyranoside C21H20O12 465 [M+H]
+ 
13.85 
8 afzelechin-(4 8″)-catechin-3-O- -
glucopyranoside 
C36H36O16 747 [M+Na]
+
 
725 [M+H]
+
 
12.60 
9 catechin C15H14O6 291[M+H]
+
 16.88 
a
UPLC/MS/MSXevo-TQ, Waters, USA. UPLC C18 column (150 mm×2.1 mm i.d.) at 25
O
C. UV 
spectrum was recorded from 190 nm to 400 nm. The mobile phase consisted of A, water containing 0.1 % 
formic acid, and B, methanol containing 0.1 % formic acid. The elution gradient was performed using a 
pump from 10 % to 100 % B for 25 min at a flow rate of 0.25 mL/min. Detection was carried over 30 min 
at a flow rate of 0.25 mL/min. Detection was carried out at 290 and 294 nm. The injection volume was            
5 μL. ESI-MS (positive ion), fullscan(m/z from 100 to 1300). 
b
Confirmed by comparison to authentic standards; 
c
Overlapped. 
2.4. Biological tests 
2.4.1. Cell culture 
The RAW 264.7 mouse macrophage cell line was obtained from the American Type Culture 
Collection (ATCC) (Manassas, VA, USA)and cultured in Dulbecco’s Modified Eagle’s Medium 
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(DMEM) supplemented with 10 % fetal bovine serum, 1 % penicillin and 1 % streptomycin. 
Cells were incubated in a humidified incubator with an atmosphere of 5 % CO2 at 37 °C. 
2.4.2. Cell viability assay 
The MTT assay was used to evaluate the effects of AT2 on cell viability. In brief, cells 
were seeded into 96-well plates at a density of 1 × 10
5
 cells/mL. Cells were treated with different 
concentrations (0, 3.125, 6.25, 12.5,25, and 50 μg/mL) of AT2 for 1 h, followed by stimulation 
with LPS (1 μg/mL) for 24 h. After incubation, 30 μL MTT (5 mg/mL) was added to each well 
and incubated for another 4 h. After replacing the culture supernatant with 100 μL dimethyl 
sulfoxide (DMSO), the optical density of the plates was read at a wavelength of 490 nm using a 
microplate reader (TECAN, Austria). 
2.4.3. Pro-inflammatory cytokine determination assay 
RAW 264.7 cells were pretreated with various concentrations (0, 3.125, 6.25, 12.5,25, and 
50 μg/mL) of AT2 for 24 h before stimulating with LPS (1 μg/mL). After 18 h incubation, the 
levels of pro-inflammatory cytokines TNF-alpha and IL-6 were measured in the supernatant 
using commercial ELISA kits (Biovision, Chester Springs, PA, USA) following the 
manufacturer’s protocols. 
2.4.4. Evaluating AT2 extract-reduced arthritis using a modelof collagen antibody-induced 
arthritis (CAIA) 
The male mice used in this study were of 10-11 weeks of age. The anti-collagen antibody 
cocktail was purchased from Modi Quest Research (Nijmegen, The Netherlands) and used 
according to the manufacturer’s instructions. Briefly, mice were intraperitoneally (IP) 
injectedwith 3 mg of the cocktail of anti-collagen antibodies. On days 3 and 9, the mice were IP 
injected with 25 μg LPS (Sigma, St. Louis, MO) to trigger the development of arthritis. Dosing 
began on day 4 after the mice had initial symptoms of arthritis. Thirty mice were assigned 
equally into five groups: the positive control (Group 1) orally received dexamethasone at a dose 
of 0.5 mg/kg body weight (bw) daily for 9 days; the negative control (Group 2) received water 
daily for 9 days; The experimented groups, of which were group 3, 4 and 5, was orally 
administered with AT2 at different doses for 9 days. Accordingly, group 3 was treated with AT2 
at a dose of 300 mg/kg bw daily; Group 4 was treated with AT2 at a dose of 200 mg/kg bw 
daily; and Group 5 was treated with AT2 at a dose of 100 mg/kg bw daily. The mice were scored 
for clinical arthritis by two observers who were blinded to the group assignments. Each paw was 
scored on a scale of 0-2 based on the signs of swelling and inflammation. Serum was collected 
from each mouse injected with anti-collagen antibodies on days 0, 4, 6, 8, 10, and 12 and stored 
at -20 °C until use. The levels of TNF-alpha and IL-6 in the sera were measured as already 
described. 
3. RESULTS AND DISCUSSION 
3.1. Phytochemical analysis  
In our previous studies, we prepared an ethyl acetate (EtOAc) extract from the leaves of the 
A.tonkinensisplant and tested its anti-inflammatory properties in a collagen-induced arthritis 
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(CIA) model,and showed that the EtOAc extract of A. tonkinensishad beneficial effects [9]. 
Phytochemical analysis indicated that the EtOAc extract contains of potentially bioactive 
glucosides such as hovetrichoside C (1), alphitonin-O- -D-glucoside (2), artonkin-4’-O- -D-
glucopyranosid and astragalin (4). All four compounds were found to have potent anti-
proliferative and anti-inflammatory effects in vitro model [7, 9]. The main compound 1 inhibited 
also the growth of OCI-AML cells [10]. Moreover, gene expression profiling identified 19 genes 
modulated by compound 1 and among them, HMOX1 and SRXN1genes were consistently and 
highly up-regulated [10]. To examine the more polar components from A. tonkinensis, AT2 was 
prepared from 70 % ethanol extraction of A. tonkinensis leaves. The use of 70 % ethanol for 
extraction resulted in higher yield of crude extract (18.3 %, w/w).On the other hand,AT2 
contains significant amounts of the same glycosides as in EtOAc extract, which are responsible 
for anticancer and anti-inflammatory activities [8, 11].Thus, in this study, AT2 was evaluated for 
potential at reducing arthritis using a CAIA model. 
Phytochemical studies using the 70 % ethanolic extract of AT2 revealed the presence of 
nine flavonoids1-9. Their structures were elucidated by electrospray ionization mass 
spectrometry (ESI-MS) and 
1
H-, 
13
C NMR spectral analysis. Nine compounds 1-9 are identified, 
including maesopsin 4-O- -glucopyranoside (1), alphitonin 4-O- -glucopyranoside (2), 
kaempferol(3),astragalin (4), kaempferol 3-O- -rutinoside(5), kaempferol 3-O- -
neohesperidoside (6), quercetin 3-O- -glucopyranoside (7), afzelechin-(4 8″)-catechin-3-O-
-glucopyranoside (8) and catechin (9) (Figure 1). The detailed qualitative analyses of AT2 
extract were performed with HPLC and HPLC-MS methods. Constituents of AT2 were 
confirmed by comparing HPLC-MS data of standard isolated compounds (Table 1) [8]. At 
present, it is difficult to attribute the observed effects of the leaves of A. tonkinensisto any one 
particular chemical moiety. 
 
Figure 1.  Structures of flavonoids (1-9) from 70% ethanolic extract of A. tonkinensisleaves (AT2). 
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3.2. A. tonkinensisleaf extract(AT2) inhibited pro-inflammatory cytokines releasing in 
LPS-stimulated RAW 264.7 macrophages 
There were no significant changes in cell viability following AT2 treatment at the tested 
concentrations (Figure 2). Therefore, non-toxic concentrations (3.125, 6.25, 12.5, 25, and 50 
µg/mL) of AT2 were used in the cytokine inhibition experiment, allowing the determination of 
the effects of AT2 on the production of pro-inflammatory cytokines in LPS-stimulated 
macrophages. Treatment with LPS resulted in a significant increase in TNF-alpha and IL-6 
production compared with the control. However, treatment with AT2 (12.5, 25 and 50 μg/mL) 
remarkably inhibited LPS-induced TNF-alpha and IL-6production in a dose-dependent manner 
(P < 0.05) (Figure 3). This led us to conclude that AT2 might have anti-inflammatory properties 
caused by the inhibition of cytokine production in LPS-induced macrophages. 
 
Figure 2.Effects of AT2 extract on cell viability in LPS-treated RAW 264.7 mouse macrophages.                  
RAW 264.7 cells were cultured with AT2 extract in the presence of LPS(1μg/mL) for 24 h. Cell viability 
was tested by MTT reduction assays. Values are presented as the mean ± standard deviation (SD) of               
three independent experiments. 
A B 
  
Figure 3.Effects of AT2 extract on the production of IL-6 (A) and TNF-alpha (B) in LPS-stimulated RAW 
264.7 cells. Cells were treated with LPS alone or LPS plus various concentrations (3.125, 6.25, 12.5, 25, 
and 50 μg/mL) of AT2 extract for 24 h. *P < 0.05, **P < 0.01 compared to LPS stimulated cells. Values 
represent the mean ± SD of three independent experiments. 
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3.3. The in vivo effect of A. tonkinensis leaf extract on CAIA 
For a possible use of 70 % ethanolic extract of A. tonkinensisleaves as alternative herb 
medicines to treat human disease, it was undertaken to evaluate its potential at reducing arthritis 
using a CAIA model. Previous toxicological studies have shown that AT2 exerted no effects on 
survival, clinical observations, macroscopic examination of organs, body weight or food, or 
water consumption in mice up to 14.50 g/kg bw (oral administration) dose. In addition, from 
sub-chronic toxic tests, AT2 did not change the behavior, body weight or histopathological 
assessment of the kidney or liver at doses of 0.6 and 1.8 g/kg body weight for 8 weeks (data not 
shown); hence doses of 100, 200 and 300 mg/kg bw were selected for the present study. 
 
 
 
Figure 4. Effect of AT2 administration at high doses caused statistically significant reductions in the 
arthritis scores compared with the vehicle-treated controls (P<0.05) (A). TNF-alpha was measured in the 
sera of AT2-treated mice at difference doses (100, 200 and 300 mg/kg body weight), together with 
negative (vehicle-treated) and positive (dexamethasone) groups (B). IL-6 levels in compliance with TNF-
alpha measured from AT2-treated groups and other control groups (C). 
The effect of the AT2 extract on signs of arthritis in the CAIA model was evaluated. Initial 
experiments were performed using the BALB/c mouse model because of its higher susceptibility 
to CAIA. On days 0 and 3, BALB/c mice were injected with 3 mg collagen antibody cocktail 
and 25 µg LPS, respectively. Animals were treated with AT2 at different concentrations from 
day 4. AT2 administration at doses of 300 mg/kg and 200 mg/kg bw caused statistically 
significant reductions in the arthritis scores compared with the vehicle-treated controls (p < 0.05) 
(Figure 4A). The arthritis scores were reduced from 9 in the control group to 5.75 and 7 at doses 
of 300 mg/kg and 200 mg/kg bw, respectively. Accordingly, these scores showed the average 
reduction of arthritis symptomatic scores to be 36.11 % and 22.22 %, respectively. In addition, 
mice treated with a daily oral dose of dexamethasone at a dose of 0.5 mg/kg bw (positive 
control) had excellent dose responsive inhibition of paw swelling over time, with activity 
peaking at 63.89 % inhibition of arthritis scores (Figure 4A). The IL-6 and TNF-alpha levels in 
the collected sera were also significantly decreased by AT2 extract at doses of 300 mg/kg and 
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200 mg/kg bw compared with those of untreated mice (Figure 4B and 4C). The data were 
entirely consistent with the level of rheumatoid arthritis symptoms shown in those mouse 
groups. 
The results indicate that the aqueous EtOH extract from A. tonkinensis leaves exerts its 
anti-inflammatory activity through decreasing arthritis scores. Moreover, reductions in arthritis 
scores were dose-related and statistically significant at doses of 200 and 300 mg/kg bw. 
Accordingly, the level of IL-6 and TNF-alpha pro-inflammatory cytokines in the sera of AT2 
extract-treated mice showed a relevant reduction.  
Flavonoids and their glycosides exhibit their anti-inflammatory effects by several 
mechanisms [14], along with a wide spectrum of other pharmacological effects such as 
analgesic, antioxidant, antimicrobial, antiviral, anticancer, antidiabetic, and antiplatelet activities 
[15, 16]. Kaempferol, quercetin, alphitonin and their glycosidic derivatives are considered potent 
immunomodulatory, anticancer, anti-inflammatory activities and antioxidant ability [17, 18]. 
Therefore, the anti-inflammatory activity of AT2 may be attributed to its total flavonoids. These 
results suggest that AT2 can inhibit the inflammatory response and may represent a potential 
therapeutic candidate for the treatment of chronic inflammatory diseases.  
4. CONCLUSIONS 
The results of the present study indicate that the 70 % ethanol extract from 
A.tonkinensisleaves exerts anti-inflammatory activity when tested in vitro and in vivo. The in 
vivo tests indicate that the arthritis scores and pro-inflammatory cytokines were significantly 
reduced at doses of 200 and 300 mg/kg body weight (P < 0.05). These promising results 
demonstrate that this plant is valuable for preparing functional foods and pharmaceutical 
medicines to treat inflammatory, rheumatism and joint disorders. 
Acknowledgements.The research was supported by a grant (NDT.33.ITA/17) from Vietnam Ministry of 
Science and Technology and by the Italian MinisterodegliAffariEsteriedellaCooperazioneInternazionale 
(MAECI). 
REFERENCES 
1. Tabas I., Glass C. K. - Anti-inflammatory therapy in chronic disease: challenges and 
opportunities. Science 339 (6116) (2013) 166-172. 
2. Guilherme L., Kalil J. - Rheumatic heart disease: Molecules involved in valve tissue 
inflammation leading to the autoimmune process and anti-s. pyogenes vaccine, Front 
Immunol 4 (2013) 352.  
3. Shrivastava A. K., Pandey A. - Inflammation and rheumatoid arthritis, J. Physiol 
Biochem. 69 (2) (2013) 335-347.  
4. Christodoulou C., Choy E. - Joint inflammation and cytokine inhibition in rheumatoid 
arthritis, Clin. Exp. Med. 6 (1) (2006) 13-19.  
5. Gullick N. J., Scott D. L. - Drug therapy of inflammatory arthritis, Clin. Med. 12 (4) 
(2012), 357-363.  
6. Thuy T. T., Kamperdick C., Ninh P. T., Lien T. T. P., Thao T. T. P., Sung T. V. - 
Immunosuppressive auronol glycosides from  Artocarpustonkinensis, Pharmazie 59 
(2004) 297-300. 
 
 
Tran Duc Quan, et al. 
294 
7. Dang D. T., Eriste E., Liepinsh E., Trinh T. T., Erlandsson-Harris H., Sillard R.,  Lasson 
P. - A novel anti-inflammatory compound, artonkin-4'-O-glucoside, from the leaves of 
Artocarpus tonkinensis suppresses experimentally induced arthritis, Scand J. Immunol 69 
(2009) 110-118. 
8. Thuy T. T., Thien D. D., Hung T. Q., Tam N. T., Anh N. T. H., L. K. Dung, T. V. Sung, 
Delfino D. V. - Flavonol  and  proanthocyanidin glycosides from the leaves of  
Artocarpustonkinensis, Chem. Nat .Compd. 53 (2017) 759-763.  
9. Ngoc D.D., Catrina A. I., Lundberg K., Harris H. E., Ha N. T., Anh P. T., Larsson P. - 
Inhibition by Artocarpus tonkinensis of the development of collagen-induced arthritis in 
rats, Scand J Immunol 61 (2005) 234-241.  
10. Pozzesi N., Pierangeli S., Vacca C., Falchi L., Pettorossi V., Martelli M.P., Thuy T. T., 
Ninh P.T., Liberati A.M.,  Riccardi C.,  Sung T.V., Delfino D. V.- Maesopsin 4-O-beta-D-
glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits 
proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia, 
J. Chemother 23 (2011) 150-157.  
11. Thuy T. T., Thien D. D., Hung T. Q., Tam N. T., Anh N. T. H., Nga N. T., Mai L. P., 
Sung T. V., Delfino D. V., Thao D. T. - In vivo anticancer activity of maesopsin 4-O-β-
glucoside isolated from leaves of Artocarpus tonkinensis A, Chev. Ex Gagnep, Asian Pac. 
J. Trop. Med. 9 (2016) 351-356. 
12. Pulichino AM, Rowland S, Wu T, Clark P, Xu D, Mathieu MC, Riendeau D, Audoly LP. -
Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia 
and chronic arthritis, J. Pharmacol Exp. Ther. 319 (3) (2006) 1043-1050. 
13. Moore A. R., Allden S., Bourne T., Denis M. C., Kranidioti K., Okoye R., Sotsios Y., 
Stelcel Z., Vugler A., Watt G., Shaw S. - Collagen II antibody-induced arthritis in 
Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human 
TNFα in rheumatoid arthritis, J. Transl. Med. 12 (1) (2014) 1-10. 
14. Romano B., Pagano E., Montanaro V., Fortunato A. L., Milic N., Borrelli F. - Novel 
insights into the pharmacology of flavonoids, Phytother Res 27 (2013) 1588-1596. 
15. Xiao J., Chen T., Cao H. - Flavonoid glycosylation and biological benefits, Biotechnol 
Adv196 (2014) 4103-4110. 
16. Zhao M., Yang B., Wang J., Liu Y., Yu L., Jiang Y. -Immunomodulatory and anticancer 
activities of flavonoids extracted from litchi (Litchi chinensis Sonn.) pericarp, Int 
Immunopharmacol 7 (2007) 162-166.  
17. Kotani M., Matsumoto M., Fujita A., Higa S., Wang W., Suemura M., Kishimoto 
T., Tanaka T. - Persimmon leaf extract and astragalin inhibit development of dermatitis 
and IgE elevation in NC/Nga mice, J. Allergy ClinImmunol 106 (1) (2000) 159-166. 
18. Kampkötter A., Timpel C., Zurawski R. F., Ruhl S., Chovolou Y., Proksch P., Watjen W. 
- Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin, 
Comparative biochemistry and Physiology Part B: Biochemistry and Molecular Biology 
149 (2008) 314-323. 
 
